Literature DB >> 6989695

Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans.

R S Bar, M Muggeo, C R Kahn, P Gorden, J Roth.   

Abstract

This report analyzes the in vitro characteristics of 125I-insulin binding to the monocytes of nine patients with the syndromes of acanthosis nigricans and insulin resistance. The 3 Type A patients (without demonstrable autoantibodies to the insulin receptor) had decreased binding of insulin due to a decreased concentration of receptors. In these patients the residual receptors demonstrated normal dissociation kinetics, negative cooperativity, and were blocked by anti-receptor antibodies in a manner similar to normal cells. In contrast, monocytes from the 6 Type B patients (with circulating anti-receptor autoantibodies) had decreased binding of insulin due to a decrease in receptor affinity. Insulin binding to monocytes of Type B patients demonstrated accelerated rates of dissociation with no evidence of cooperative interactions among insulin receptors. When coupled with previous data, the present studies further suggest that different mechanisms account for the defects in insulin binding and insulin resistance observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989695     DOI: 10.1007/BF00251918

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Cooperativity in ligand binding: a new graphic analysis.

Authors:  P De Meyts; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

2.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  The underlying insulin receptor in patients with antireceptor autoantibodies: demonstration of normal binding and immunological properties.

Authors:  M Muggeo; C R Kahn; R S Bar; M Rechler; J S Flier; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

4.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

5.  Anti-insulin receptor antibodies and diabetes.

Authors:  W G Blackard; J H Anderson; F Mullinax
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

6.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.

Authors:  R S Bar; W R Levis; M M Rechler; L C Harrison; C Siebert; J Podskalny; J Roth; M Muggeo
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

8.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism.

Authors:  M Kobayashi; J M Olefsky; J Elders; M E Mako; B D Given; H K Schedwie; R H Fiser; R L Hintz; J A Horner; A H Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  13 in total

Review 1.  Insulin receptors and the clinician.

Authors:  R Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

2.  Autoantibodies to hormone receptors.

Authors:  L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: decreased sensitivity to alterations in temperature and pH.

Authors:  S I Taylor; J Roth; R M Blizzard; M J Elders
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

Review 4.  Hormone-producing tumors of the ovary.

Authors:  Ara Chalvardjian
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

5.  Non-insulin dependent diabetes mellitus in Mexican-American children.

Authors:  N S Glaser; K L Jones
Journal:  West J Med       Date:  1998-01

Review 6.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

7.  Pathogenetic mechanisms of hereditary diabetes mellitus.

Authors:  H W Rüdiger; M Dreyer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Pancreatic A and B cell hyperfunction in the Mendenhall syndrome.

Authors:  M Serrano Ríos; S de la Viña; M E Carbó; R E Nash; R Barrio; L G Heding
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

9.  Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.

Authors:  R F Dons; R Havlik; S I Taylor; K L Baird; S S Chernick; P Gorden
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462.

Authors:  A Cama; M L Sierra; T Kadowaki; H Kadowaki; M J Quon; H W Rüdiger; M Dreyer; S I Taylor
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.